VeriMom3-hydroxybutyric acid hamilelikte güvenli mi?
No evidence of reproductive or teratogenic effects in available regulatory summaries. PubChem GHS entries list skin/eye irritation (H315, H319, H335) but these are aggregated notifications and not harmonised reproductive classifications. No harmonised CLP (ECHA Annex VI) reproductive flags or SCCS/CIR safety assessment found in the provided sources, so hazard and mechanism scores remain 0. Systemic exposure from topical use is expected to be low but measurable (small, water‑soluble molecule), so exposure = 1 (low). Sources: PubChem GHS (aggregate notifications); absence of harmonised classification in ECHA Annex VI / no SCCS/CIR found in provided databases.
Related ingredients
Frequently asked questions
- 3-hydroxybutyric acid hamilelikte güvenli mi?
- No evidence of reproductive or teratogenic effects in available regulatory summaries. PubChem GHS entries list skin/eye irritation (H315, H319, H335) but these are aggregated notifications and not harmonised reproductive classifications. No harmonised CLP (ECHA Annex VI) reproductive flags or SCCS/CIR safety assessment found in the provided sources, so hazard and mechanism scores remain 0. Systemic exposure from topical use is expected to be low but measurable (small, water‑soluble molecule), so exposure = 1 (low). Sources: PubChem GHS (aggregate notifications); absence of harmonised classification in ECHA Annex VI / no SCCS/CIR found in provided databases.
- 3-hydroxybutyric acid emzirirken güvenli mi?
- No data indicating reproductive or lactation-specific toxicity. As an endogenous small molecule (beta/3‑hydroxybutyric acid is a normal ketone body), no signals for lactation hazards were identified in the provided regulatory sources. Topical cosmetic use could produce low systemic levels — therefore exposure scored as 1 (low). Sources: PubChem GHS; no SCCS/CIR or harmonised ECHA reproductive classification identified.
- 3-hydroxybutyric acid bebek cildi için güvenli mi?
- No infant-specific developmental toxicity evidence located in the provided sources. Hazard and mechanism remain 0. Because infant skin has a higher surface‑area‑to‑weight ratio and immature barrier, exposure score is increased by +1 relative to adult topical use (adult e=1 → infant e=2), reflecting moderate potential for percutaneous absorption in 0–3 yr olds. Sources: PubChem GHS (aggregate notifications); ECHA/CosIng/CIR searches yielded no harmonised reproductive or infant‑specific safety assessments in the provided dataset.
- VeriMom 3-hydroxybutyric acid nasıl puanlıyor?
- VeriMom 3-hydroxybutyric acid'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte 3-hydroxybutyric acid yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.